SARASOTA, Florida, June 27, 2017 /PRNewswire/ --
International Consolidated Companies, Inc. (INCC) has entered into a definitive agreement to acquire CBD product developer BluDog Products LLC ("BluDog"). The consideration for the purchase is 5,000,000 shares of Preferred Z stock to be designated. Pursuant to the agreement, the seller shall receive additional Bonus shares if sales exceed BluDog's projections. If BluDog achieves sales of $7,000,000 in 2018 INCC shall issue 1,000,000 Bonus Preferred Z shares. If BluDog achieves sales of $21,000,000 in 2019 INCC shall issue 4,000,000 Bonus Preferred Z shares.
BluDog Products is strategically introducing a water-soluble CBD oil super food and wellness drinks (with an extended release formulation) that are easily absorbed. Using a licensed, patented CBD delivery system Bulldog's CBD products are an alternative over-the-counter therapeutic option to help relieve post-sports inﬂammation as well as promote relaxation and well-being. Bulldog's CBD products interact naturally with the body's anti-inﬂammatory system without any known side eﬀects.
BDP is tapping into a multi-billion dollar market for eﬀective, non-addictive and non-opioid pain relief products that have no known side eﬀects. With the demand for pain solutions, many prescribed products have come under scrutiny. Prescription drug abuse is currently the nation's fastest growing drug addiction.*
According to the American Pain Society, pain is the most common symptom that causes people to seek medical care. The global market for pain management by revenue at manufacturers' sales levels is projected to grow from $33.6 billion in 2014 to nearly $34.8 billion in 2015, and $41.3 billion in 2020, with a compound annual growth rate (CAGR) of 3.2% between 2015 and 2020. Sales in the U.S. represent approximately 48% of the total market. BDP is focusing on the over-the- counter segment of this market.**
Pain and inﬂammation are chronic issues that plague an active and aging population. Pain has been medicated the same way for 40 years using over-the-counter pain relief products or prescription opioids. This consumer category has very few alternative solutions, creating a tremendous opportunity for innovative, ethical, quality and eﬀective solutions.
Bulldog has developed proprietary, innovative CBD products to fulﬁll the demand in the burgeoning pain relief market. There is a lack of eﬀective, non-addictive pain relief products creating a huge void and demand for safe innovative treatments which Bulldog seeks to fill.
The competition in the water-soluble CBD category is very limited. There are only a few companies that sell water-soluble CBD and their product oﬀerings include only one or two items, which are liquid based. Bulldog oﬀers a proprietary water-soluble CBD solution with an extended release formulation providing relief on a consistent level over time. Bulldog intends to oﬀer a variety of ingestible and topical products, as well as a balm.
**The Global Market for Pain Management Drugs and Devices, September 2015;
International Consolidated Companies, Inc.
International Consolidated Companies (INCC) was founded in 2002. INCC is focused on acquiring and growing businesses that offer innovation, quality, and cost-efficient Cannabis technologies.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material may contain statements about expected future events and/or financial results that are forward-looking in nature and subject to risk and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements to be materially different from the statements made herein.
More Information: Antonio F. Uccello, INCC;
8191 North Tamiami Trail
Sarasota, FL 34243
SOURCE International Consolidated Companies, Inc.